Bids Are Invited For Price Registration For The Eventual Acquisition Of General Clinical Medicines 8 (Sei No. 0040609437.000092/2024-31)

(3094090) - Acetylcysteine ​​- Concentration/Dosage 100 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form, Parenteral Administration Route, (4029941) - Polyacrylic Acid - Concentration/Dosage 2 Mg/G, Pharmaceutical Form Ophthalmic Gel, Form Presentation Tube, Ophthalmic Administration Route, (3413110) - Alteplase - Concentration/Dosage 50 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Vial-Ampule + Diluent, Intravenous Administration Route, (3097501) - Aminophylline - Concentration /Dosage 100 Mg, Tablet Pharmaceutical Form, Tablet Presentation Form, Oral Administration Route, (4164164) - Methylene Blue - Concentration/Dosage 20 Mg/Ml, 08/14/2024, (3427609) - Methylene Blue - Concentration /Dosage 40 Mg/Ml, (3085309) - Benzyl Benzoate - Concentration/Dosage 250 Mg/Ml, Pharmaceutical Form Topical Emulsion, Bottle Presentation Form, Topical Administration Route, (3109232) - Budesonide - Concentration/Dosage 0.50 Mg/Ml, Pharmaceutical Form Nebulization Suspension, Inhalation Route Of Administration, (3068595) - Captopril - Concentration/Dosage 12.5 Mg, (3444163) - Sodium Carboxymethycellulose - Concentration/Dosage 5 Mg/Ml, Pharmaceutical Form Ophthalmic Solution, ( 3160963) - Cyclopentolate, Hydrochloride - Concentration/Dosage 10 Mg/Ml, (3106772) - Ciprofloxacin, Hydrochloride + Dexamethasone - Concentration/Dosage 3.5 Mg/Ml + 1 Mg/Ml Respectively, Presentation Form Dropper Bottle, ( 3107817) - Clonidine, Hydrochloride - Concentration/Dosage 0, 100 Mg, (3513645) - Clonidine, 150 Mg, (3201007) - Aluminum Hydroxide - Concentration/Dosage 62 Mg/Ml, Pharmaceutical Form Oral Suspension, (3190080) - Immunoglobulin Antitetanus Human - Concentration/Dosage 250 Iu/Ml, Intramuscular Administration Route, (3086429) - Human Insulin - Nph Type, Concentration/Dosage 100 Iu/Ml, Pharmaceutical Form Injectable Suspension, Vial-Ampule Presentation Form, (3086402) - Human Insulin - Regular Type, (3082989) - Lidocaine, Hydrochloride - Concentration/Dosage 20 Mg/G, Pharmaceutical Jelly Form, Presentation Form Tube + Applicator, (3212645) - Lidocaine, Hydrochloride + Glucose - Concentration/Dosage 50 Mg/Ml + 75 Mg/Ml Respectively, Intrathecal Route Of Administration, (3183394) - Loperamide, Hydrochloride - Concentration/Dosage 2 Mg, (3352773) - Mepivacaine, Hydrochloride + Norepinephrine - Concentration/Dosage 20 Mg/Ml + 18 Mcg/Ml Respectively, Tube Presentation Form, Percutaneous Or Parenteral Administration Route, (3771270) - Mepivacaine, Hydrochloride + Epinephrine - Concentration/Dosage 20 Mg/Ml + 0.01 Mg/Ml Respectively, Carpule Presentation Form, (3196631) - Promethazine, Hydrochloride - Concentration/Dosage 25 Mg, (3198073) - Potassium Permanganate - Concentration/Dosage 100 Mg, (3200604) - Salbutamol, Sulfate - Concentration/Dosage 0.4 Mg/Ml, Pharmaceutical Form Syrup, (3230147) - Barium Sulfate - Concentration/Dosage 1 G/G, Pharmaceutical Form Gel, Pot Presentation Form, (3235823) - Fibrin Sealant - Composition 1 Aprotinin 1000 To 3000 Uic/Ml + Coagulation Factor Xiii 10 To 40 U/Ml, Composition 2 Fibrinogen 80 To 120 G/L + Thrombin 300 To 600 Iu/Ml, Presentation Form Vial-Ampule + Reconstitution And Application Kit, Intralesional And Topical Administration Route, (3196305) - Thiabendazole - Concentration/Dosage 500 Mg